1. Aggarwal, B. B. 2004. Nuclear factor-κB: the enemy within. Cancer Cell6:203-208.
2. Akiyama, M., T. Hideshima, T. Hayashi, Y.-T. Tai, C. S. Mitsiades, N. Mitsiades, D. Chauhan, P. Richardson, N. C. Munshi, and K. C. Anderson. 2002. Cytokines modulate telomerase activity in a human multiple myeloma cell line.Cancer Res.62:3876-3882.
3. Akiyama, M., T. Hideshima, T. Hayashi, Y.-T. Tai, C. S. Mitsiades, N. Mitsiades, D. Chauhan, P. Richardson, N. C. Munshi, and K. C. Anderson. 2003. Nuclear factor-κB p65 mediates tumor necrosis factor α-induced nuclear translocation of telomerase reverse transcriptase protein.Cancer Res.63:18-21.
4. Akiyama, M., O. Yamada, N. Kanda, S. Akita, T. Kawano, T. Ohno, H. Mizoguchi, Y. Eto, K. C. Anderson, and H. Yamada. 2002. Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors. Cancer Lett.178:187-197.
5. Akiyama, Y., and S. Kato. 1974. Two cell lines from lymphomas of Marek's disease. Biken J.17:105-116.